AI assistant
LIGAND PHARMACEUTICALS INC — Director's Dealing 2017
Mar 1, 2017
31289_dirs_2017-02-28_92b401f7-6d88-4fd5-987f-6ce50aed2cc3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LIGAND PHARMACEUTICALS INC (LGND)
CIK: 0000886163
Period of Report: 2016-08-06
Reporting Person: Korenberg Matthew E (VP, Finance and CFO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-08-06 | Common Stock | F | 609 | $123.3 | Disposed | 9457 | Direct |
| 2017-02-15 | Common Stock | F | 391 | $104.28 | Disposed | 9106 | Direct |
| 2017-02-24 | Common Stock | A | 3450 | $0.0 | Acquired | 12556 | Direct |
| 2017-02-24 | Common Stock | F | 1051 | $100.38 | Disposed | 11505 | Direct |
| 2017-02-24 | Common Stock | A | 3567 | $0.0 | Acquired | 15072 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-02-24 | Employee Stock Option (right to buy) | $100.38 | A | 15225 | Acquired | 2027-02-24 | Common Stock (15225) | Direct |
Footnotes
F1: Represents shares withheld to satisfy tax withholding obligations upon the vesting of previously reported restricted stock units that were granted on 08/06/2015.
F2: Represents shares withheld to satisfy tax withholding obligations upon the vesting of previously reported restricted stock units that were granted on 02/11/2016.
F3: Represents the number of shares of common stock issued upon the vesting of performance stock units (PSUs). Each PSU represented a contingent right to receive one share of the Issuer?s common stock. The PSUs were originally granted on 02/10/2015 and were eligible to vest based on the Issuer?s achievement of certain performance objectives during the two-year performance period ending December 31, 2016. On February 24, 2017, the Compensation Committee of the Board of Directors of the Issuer certified the Issuer?s achievement relative to the applicable performance objectives and approved the vesting of the PSUs with respect to these shares.
F4: Represents shares withheld by the Issuer in payment of the tax liability arising in connection with the settlement of the PSUs.
F5: Grant to reporting person of options, exercisable over a 4-year period measured from the date of grant, 12-1/2% after six months, then 1/48th of the Optioned Shares per month thereafter.